Abliva AB

Abliva AB

  • Price (EUR)0.0165
  • Today's Change-0.001 / -7.30%
  • Shares traded0.00
  • 1 Year change-46.15%
  • Beta--
Data delayed at least 15 minutes, as of Mar 20 2023.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

  • Revenue in SEK (TTM)31.00k
  • Net income in SEK-85.26m
  • Incorporated2000
  • Employees8.00
  • Location
    Abliva ABMedicon Village, Scheeletorget 1LUND 223 81SwedenSWE
  • Phone+46 462756220
  • Fax+46 468888348
  • Websitehttps://abliva.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.